YOURGENE HEALTH UK LTD
Yourgene Health is a Manchester-based molecular diagnostics company and subsidiary of Novacyt UK Holdings Limited that develops gene analysis techniques and in vitro diagnostic products, including non-invasive prenatal screening tests.
Get an alert when YOURGENE HEALTH UK LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.2M
-25.9% vs 2024
Net assets
-£45M
-26.1% lowest in 3 filed years
Employees
153
+61.1% highest in 3 filed years
Profit before tax
-£9.2M
-53.6% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £8,806,000 | £11,203,000 | £13,224,000 | +18% | |
| Operating profit | -£8,140,000 | -£3,898,000 | -£7,024,000 | -80.2% | |
| Profit before tax | -£8,910,000 | -£5,956,000 | -£9,150,000 | -53.6% | |
| Net profit | -£9,465,000 | -£5,749,000 | -£9,376,000 | -63.1% | |
| Cash | £1,042,000 | £1,597,000 | £1,183,000 | -25.9% | |
| Total assets less current liabilities | -£30,000,000 | -£35,821,000 | -£45,244,000 | -26.3% | |
| Net assets | -£30,136,000 | -£35,885,000 | -£45,261,000 | -26.1% | |
| Equity | — | — | — | — | |
| Average employees | 93 | 95 | 153 | +61.1% | |
| Wages | £3,395,000 | £4,220,000 | £6,196,000 | +46.8% | |
| Directors' remuneration | — | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -92.4% | -34.8% | -53.1% | |
| Net margin | -107.5% | -51.3% | -70.9% | |
| Gearing (liabilities / total assets) | 550.5% | 522.8% | 648.8% | |
| Current ratio | 0.13x | 0.15x | 0.13x | |
| Interest cover | -8.85x | -1.36x | -2.24x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- YOURGENE HEALTH UK LTD 2019-12-11 → present
- PREMAITHA LIMITED 2014-07-03 → 2019-12-11
- PREMAITHA HEALTH LTD 2013-03-08 → 2014-07-03
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Constantin
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have, at the time of approving the financial statements, a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the financial statements after having taken into account the available information they have for the future, and especially the cash forecast prepared for the next 12 months.”
Significant events
- “As the geopolitical environment evolves and global markets continue to struggle, Management continues to closely monitor the Middle East conflict and the impact it could have on the business from both a supplier and customer perspective. At present it has not had a material impact.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GIBSON, Steven Michael | Director | 2023-09-08 | Sep 1982 | British |
| REES, Lyn Dafydd | Director | 2019-01-02 | Mar 1973 | British |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HEXTALL, Barry Kenneth | Secretary | 2023-03-31 | 2023-09-29 |
| COLLINGBOURNE, Mark Kingsley | Director | 2014-07-04 | 2014-07-05 |
| DENMAN IV, William Tocor, Dr | Director | 2013-09-20 | 2015-10-01 |
| EVANS, David Eric | Director | 2013-09-20 | 2015-10-01 |
| HEXTALL, Barry Kenneth | Director | 2015-09-18 | 2023-03-31 |
| JEFFREYS, Hayden William | Director | 2019-01-02 | 2023-03-31 |
| LAWSON, Stuart John | Director | 2013-03-08 | 2014-07-04 |
| LITTLE, Stephen, Dr | Director | 2015-10-01 | 2019-01-03 |
| LYWOOD, Rupert Charles Gifford | Director | 2013-03-08 | 2013-09-20 |
| MASON, Joanne Nicola, Dr | Director | 2023-01-01 | 2026-05-07 |
| RISLEY, Michael David, Dr | Director | 2019-01-02 | 2022-06-30 |
| ROBERTS, Charlie Edward Selkirk | Director | 2013-09-20 | 2015-10-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Yourgene Health Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 87 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-31 | AA | accounts | Accounts with accounts type full | |
| 2026-05-07 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-03-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-17 | AA | accounts | Accounts with accounts type full | |
| 2025-03-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-25 | AA | accounts | Accounts with accounts type full | |
| 2024-03-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-03-13 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-01-14 | AA | accounts | Accounts with accounts type full | |
| 2023-11-30 | AA01 | accounts | Change account reference date company current shortened | |
| 2023-10-24 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-09-29 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-09-11 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-11 | TM01 | officers | Termination director company with name termination date | |
| 2023-04-06 | TM01 | officers | Termination director company with name termination date | |
| 2023-04-06 | AP03 | officers | Appoint person secretary company with name date | |
| 2023-03-27 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-03-24 | AA | accounts | Accounts with accounts type full | |
| 2023-03-22 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.